GlassScriptPhysician profile
Denay Marino
NPI 1215006341
$2,658.41
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $1,121 · 2021: $956 · 2022: $14.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $618.42 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.42 | 2019-2021 | |
| Abbvie INC. | $277.65 | 2021 | |
| Lilly USA, LLC | $191.13 | 2020-2021 | |
| Amgen INC. | $187.24 | 2019-2021 | |
| Glaxosmithkline, LLC. | $155.49 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $154.82 | 2019-2021 | |
| Allergan, INC. | $138.93 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.87 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $75.20 | 2020-2021 | |
| Corcept Therapeutics | $67.06 | 2021 | |
| Pfizer INC. | $66.30 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $53.86 | 2021 | |
| Amarin Pharma, INC. | $42.57 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $25.25 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $25.07 | 2021 | |
| Ironwood Pharmaceuticals, INC | $24.16 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.05 | 2021 | |
| Currax Pharmaceuticals LLC | $14.03 | 2021 | |
| Lundbeck LLC | $11.89 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denay Marino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.